Introduction
The importance of mitochondrial dysfunctions during apoptosis induced by anticancer drugs is well documented (Szew1czyk and Wojtczak, 2002; Solary et al., 2003) . In particular, mitochondrial permeability transition is considered a critical early event in the apoptotic process Zamzami et al., 1996; Kroemer and Reed, 2000) . Changes in the function of mitochondria associated proteins is very frequently reported upon exposure of tumor cells to various classes of anticancer agents. Less frequent is the observation of alterations of the mitochondrial structure and mass which accompany the functional changes. Drug-induced proliferation of mitochondria has been sporadically reported in the literature, for example upon treatment of colon cancer cells with the tyrosine kinase inhibitor herbimycin A and with hematopoietic stem cells exposed to the topoisomerase II poison etoposide (Reipert et al., 1995; Mancini et al., 1997) . These studies established a link between apoptosis and changes in the structure and mass of mitochondria. Doxorubicin (DOXO), one of the most extensively used anticancer agents, is a high-affinity, sequenceselective DNA intercalating agent targeting topoisomerase II. DNA damages and formation of reactive oxygen species (ROS) are primarily responsible for its cytotoxic effects (Gewirtz, 1999) . This drug is employed in many chemotherapy regimens for the treatment of acute leukemia, non-Hodgkin's lymphoma and different types of solid tumors such as breast, liver and colon cancers for example. Unfortunately, despite its potent antitumor effects, DOXO is not a safe drug and its use is associated with unwanted side effects, especially a cardiac toxicity which is common to most anthracycline derivatives (Zucchi and Danesi, 2003) . DOXO induces mitochondria-dependent apoptosis in heart and cardiomyocytes (Arola et al., 2000; Rebbaa et al., 2001; Green and Leeuwenburgh, 2002) and it is assumed that cardiomyocytes apoptosis is responsible, at least in part, for DOXO-induced cardiotoxicity.
Mitochondrial dysfunctions have been observed in the heart and also in tumors of animal treated with DOXO (Solem et al., 1996; Bellarosa et al., 2001; Zhou et al., 2001; Childs et al., 2002) , and these studies demonstrated that cardiac damages caused by DOXO involve a mechanism distinct from that implicated in tumor cell killing. To clarify the differences, we decided to compare the effects of two well-established anthracycline anticancer drugs, DOXO and mitoxantrone (MITO), on mitochondrial structure and function in cardiac vs tumor cells. Using complementary cytometry and electron microscopy approaches, we characterized the drug-induced apoptotic effects and more specifically the mitochondrial changes in different tumor and nontumor cells, with special emphasis on two cell lines, mammary adenocarcinoma MTLn3 cells and H9C2 cardiomyocytes. We report an unprecedented case of mitochondrial proliferation induced by anthracyclines in cancer cells but not in cardiomyocytes.
Results

Toxicity of DOXO and MITO to H9C2 and MTLn3 cells
A conventional trypan blue exclusion assay was used to evaluate the cytotoxic effects of DOXO and MITO on the cardiomyocyte cell line H9C2 and the breast cancer cell line MTLn3. In all cases, a dose-dependent cytotoxic effect was observed. After 24 h, the LD 50 values were evaluated. As indicated in Table 1 , the values for the two drugs were higher in H9C2 cells than in MTLn3 cells indicating that, as expected, the cancer cell line was more sensitive to drug-induced cytotoxicity compared to the cardiac cell line. In both cell types, DOXO was more potent than MITO. In the following experiments, concentrations corresponding to the LD 50 values at 24 h were used to study the biological effects of the two drugs.
Drug-induced apoptosis in H9C2 and MTLn3 cells
Treatment of H9C2 and MTLn3 cells with the two drugs at their respective LD 50 value for 24 h led to marked Doxorubicin-induced proliferation of mitochondria J Kluza et al changes of the cell cycle profiles ( Figure 1A ). The flow cytometric analysis of propidium iodide (PI)-stained cells showed that DOXO and MITO induced the appearance of a hypoploid DNA content (sub-G1) peak, characteristic of nuclear apoptosis in both cell types. In agreement with the trypan blue staining data, we observed that MTLn3 cells were more sensitive to drug-triggered apoptosis compared to H9C2 cells and DOXO proved to be more effective than MITO at inducing nuclear apoptosis in both cell types. The appearance of the sub-G1 population was accompanied by typical morphological changes ( Figure 1B ). The cellular and nuclear morphology was analysed by Papanicolaou ( Figure 1B , panel a) and DAPI (4 0 -6-diamidino-2-phenylindole dihydrochloride) ( Figure 1B , panel b) staining, respectively. Cytoplasm and chromatin condensation, common features of apoptosis, were detected in both cell types at 24 h of drug treatment. Furthermore, nuclear disintegration and apoptotic bodies formation were also frequently observed in drug-treated MTLn3 cells. These features characteristic of the late degradation phase of apoptosis were also found in drug-treated H9C2 cells at 48 h (data not shown). In situ nuclear DNA fragmentation was evaluated using the TUNEL technique ( Figure 1B , panel c). As compared to untreated cells, a TUNELpositive fraction was detected exclusively in drug-treated H9C2 and MTLn3 cells. Altogether, the data establish that both DOXO and MITO are potent inducers of apoptosis both in H9C2 cardiomyocytes and MTLn3 breast cancer cells.
Drug-promoted generation of peroxides in H9C2 and MTLn3 cells
To characterize the drug-induced pro-oxidant cell response, the generation of free radicals in H9C2 and MTLn3 cells was determined by flow cytometry using the cell-permeable peroxide-sensitive fluorescent probe H 2 DCF-DA (2 0 ,7 0 -dichlorofluorescein diacetate ). This probe serves to detect the generation of intracellular free radicals (mostly peroxides but not exclusively). Once inside cells, H 2 DCF-DA is hydrolysed to DCF, which is trapped in the cell compartment. In the presence of H 2 O 2 , peroxides or peroxinitrites, DCF is oxidized to give the fluorescent product 2 0 ,7-dichlorofluorescein, which can be readily detected by flow cytometry. As shown in Figure 2a , the two drugs stimulated the generation of free radicals in both H9C2 and MTLn3 cells. The peroxides production was slightly higher in MTLn3 cells than in cardiomyocytes exposed for 24 h to LD 50 concentrations of the test drugs. A time course analysis of the drug-induced generation of peroxides was also performed (Figure 2b) . In MTLn3 cells, a significant increase in peroxides production was detected within 4 h and this preceded nuclear apoptosis. In H9C2 cells, peroxides production was rather a late event (occurring 416 h of exposure to the drugs) ( Figure 2b ) and this coincided with the development of the apoptotic morphology of the cell nuclei (Figure 1b) .
Drug-induced caspase-3 activation in MTLn3 and H9C2 cells
Numerous apoptotic stimuli including chemotherapeutic agents lead to the activation of the effector or downstream caspases (mainly caspase-3) responsible for the cleavage of crucial substrates in the final degradation phase of cell death (Earnshaw et al., 1999; Mow et al., 2001) . To investigate the activation of caspase-3, cleaved caspase-3 was studied by immunoblotting ( Figure 3a) . The caspase-3 cleavage was observed early, 4-8 h after DOXO treatment in MTLn3 cells. In contrast, a weaker extent of caspase-3 cleavage was detected in H9C2 cells at a later stage, only after 16-20 h of incubation with DOXO. In parallel, we compared caspase-3 like activities in both DOXO-treated cell lines by means of a fluorescence assay. As shown in Figure 3b , the treatment with DOXO resulted in a high increase of caspase-3-like activities in MTLn3 cells reaching a maximum after 20 h, while in H9C2 cells induction of caspase-3-like activities by DOXO was much lower even after long time exposure. These results suggest that capase-3 activation plays a major role in MTLn3 cells, whereas it is not a major contributor of apoptosis in DOXO-treated H9C2 cells. Both caspase-3-dependent and -independent pathways have been previously described in studies with H9C2 cells (Neuss et al., 2001; Bonavita et al., 2003) .
Drug-induced changes in mitochondrial transmembrane potential and mitochondrial mass
Mitochondrial changes, including variations in mitochondrial membrane potential (DC m ), are the key events during drug-induced apoptosis. A kinetic analysis of the appearance of the main signs of apoptosis in DOXOtreated cells revealed a rapid release (within 4 h) of the mitochondrial proteins AIF and cytochrome c into the cytosol of MTLn3 and H9C2 cells (Figure 4) . To monitor the DC m , we chose the dye JC-1 (5,5 0 ,6,6 0 -Tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazolcarbocyanine) which has been shown to be more specific for mitochondria than other fluorescent dyes such as DiOC 6 (3) or rhodamine 123, for examples (Salvioli et al., 1997; Ly et al., 2003) . Mitochondria with normal DC m concentrate JC-1 into aggregates (red/orange fluorescence), while in depolarized mitochondria JC-1 forms monomers (green fluorescence). As compared with untreated H9C2 cells, DOXO-and MITO-treated H9C2 cells exhibit a reduced JC-1 aggregation (shift from red/orange fluorescence to green fluorescence), an observation that reflects a drop in DC m ( Figure 5a ). As a control, H9C2 cells were incubated with mClCCP, an uncoupling agent that completely abolishes the DC m , prior to analysis. In contrast, under the same experimental conditions, no shift from orange/red to green fluorescence was observed in drug-treated MTLn3 cells when compared to the control mClCCP-treated MTLn3 cells ( Figure 5a ). We observed, however, a significant ( 1 2 log) increase in the incorporation of the monomeric forms of JC-1 (green) into drug-treated MTLn3 cells despite the fact that the JC-1 aggregates (red/orange) remained unchanged. This particular profile of JC-1 staining (increased of the green fluorescence without changes in the orange/red intensity) has been previously reported to reflect an increase in mitochondrial mass (Mancini et al., 1997; Camilleri-Broet et al., 1998) . Since in MTLn3 cells, we observed a dissociation between mitochondrial mass and DC m (increase in JC-1 green fluorescence without a corresponding increase in JC-1 orange/red fluorescence), the cellular mitochondrial membrane potential per unit mitochondrial mass declined, indicating therefore a relative decrease in DCm. Uncoupling of DOXO-and MITO-treated MTLn3 cells with mClCCP can reduce further the incorporation of JC-1 into cells. Thus, we concluded that the DC m is not completely disrupted in drug-treated MTLn3 cells. These results suggest that the drugs induce an increase of the mitochondrial mass associated with a relative DC m decrease in MTLn3 cells. Additional flow cytometry analyses were then performed using two other fluorescent dyes to validate this hypothesis. To investigate specifically the changes in mitochondrial mass, cells were stained with mitotracker green (MTG), a mitochondrial probe that accumulates in mitochondria regardless of mitochondrial membrane potential. Kinetic studies revealed a progressive increase in mitochondrial mass of drug-treated MTLn3 cells (Figure 5b ). The doxorubicin-dependent increase in In contrast, only a slight increase in mitochondrial mass was observed in H9C2 cells for 20 h of incubation with DOXO and no increase was observed in rat cardiomyocytes even after a 24 h treatment with DOXO (data not shown). The same results were obtained with nonyl-acridine orange staining, a well-established method for studies of mitochondrial mass in flow cytometry (data not shown). Overall, these results indicate that drug-triggered apoptosis was associated with different mitochondrial events in cancer cells compared to cardiomyocytes.
Mitochondrial proliferation in DOXO-treated MTLn3 cells
The above results prompted us to use transmission electronic microscopy to visualize apoptosis-associated changes in mitochondrial mass, as suggested from the flow cytometry data. Untreated MTLn3 cells exhibit a nuclear heterochromatin with a centrally located nucleus (Figure 6a ). Mitochondria were heterogeneous in shape, rounded or elongated, with numerous cristae (Figure 6b After 18 h of DOXO treatment, no major changes in mitochondrial morphology was observed, especially no swollen mitochondria were seen. Inner and outer mitochondrial membranes appeared intact and the matrix integrity was fully preserved (Figure 6e ). The number of mitochondria per MTLn3 cells, however, seemed to be increased after DOXO treatment, therefore supporting the JC-1 and MTG fluorescence results (Figure 6c vs Figure 6a ). A precise enumeration of mitochondria per cell was performed to confirm these observations. The statistic analysis shows a mean of 11.3 mitochondria per untreated MTLn3 cell (n ¼ 150) vs a mean of 16.7 mitochondria per DOXO-treated MTLn3 cell (n ¼ 151). The difference was statistically significant with P-value o10 À6 . DOXO-treated H9C2 cells (Figure 7c and d) showed a dense perinuclear condensation, in agreement with the DAPI fluorescence microscopy data mentioned above. Moreover, in nonadherent treated cells abundant autophagic vacuoles and their reticulum endoplasmic (RE) appeared swollen (Figure 7c and e) as compared to the RE of untreated cells (Figure 7a and b) . Mitochondria from untreated H9C2 cells were rounded or oval in shape with well-defined cristae (Figure 7a ). H9C2 cells treated for 18 h with DOXO showed dramatic mitochondria swelling (Figure 7c and e) . In some mitochondria, the outer membrane was clearly disrupted (Figure 7e) . As compared to control cells, no significant increase in the number of mitochondria was (Figure 8b) show that the number of mitochondria increased only in cells with altered nuclei with a mean of 21.7 against a mean of 12.8 mitochondria per cell in cell with intact nucleus. This result suggests that mitochondrial proliferation was concomitant with nuclear apoptosis in DOXO-treated MTLn3 cells. 
Mitochondrial proliferation in H2O2-treated cells
The results above suggest that the production of R OS may play a role in the proliferation of mitochondria in DOXO-treated MTLn3 cells. In this case, a decrease in the oxidative stress should prevent the proliferation of mitochondria in DOXO-treated MTLn3 cells. To test this hypothesis, several antioxidants including N-acetylcysteine, vitamin C or vitamin E (up to 10 mM) were added to MTLn3 cells at the time of treatment with DOXO. Unfortunately, we were unsuccessful at inhibiting significantly the production of ROS in DOXO-treated MTLn3 cells. In all cases, the inhibition never exceeded 20% (data not shown).
Nevertheless, to substantiate the role of ROS in DOXO-induced mitochondria proliferation, we studied the effects of the oxidative stress on the mitochondrial mass in MTLn3 and H9C2 cells. H9C2 and MTLn3 cells were treated with graded concentrations of H 2 O 2 for 24 h and the mitochondrial mass was monitored with MTG. As shown in Figure 9 , the H 2 O 2 treatment induces an increase of the fluorescence of the dye in both cell types, reflecting a significant increase of the mitochondrial mass. Interestingly, MTLn3 cells are much more sensitive to H 2 O 2 than H9C2 cells and indirectly, this observation may explain the larger effect seen with DOXO on MTLn3 cells compared to H9C2 cells. Although indirect, these experiments suggest a link between production of ROS and increase of the mitochondrial mass (see Discussion). In other words, the proliferation of mitochondria in DOXO-treated cancer cells would be dependent on the oxidative stress (see Discussion). 
Discussion
DOXO and MITO display a comparable mechanism of action. They are both potent DNA intercalating agents targeting topoisomerase II and form complexes with Fe III (Herman et al., 1997) . However, the anthracenedione MITO is much less cardiotoxic than the anthracycline DOXO (Alderton et al., 1992) . Here, we have characterized the induction of apoptosis in MTLn3 and H9C2 cells by DOXO and MITO and focused on the effects of the drugs at the mitochondrial level. We present evidences for a correlation between (i) the changes in the architecture and number of mitochondria and (ii) the drug-induced perturbation of the cell cycle progression and (iii) apoptosis.
The MTLn3 cell line, which is a common rat model for breast cancer, has been previously used to study DOXO-induced cytotoxicity and apoptosis. Caspase activation, phosphatidylserine (PS) externalization and DNA fragmentation were observed in MTLn3 cells exposed to DOXO (Huigsloot et al., 2001 (Huigsloot et al., , 2002 . These effects are likely related to DOXO-induced DNA damages also previously characterized in this rat breast tumor model (Evans et al., 1986) . The apoptotic effects correlate with the antitumor activity of DOXO, as evidenced in the corresponding MTLn3 in vivo model (Toyota et al., 1998) . DOXO-induced apoptosis in MTLn3 cells is known to cause mitochondrial perturbations. The collapse of the mitochondrial membrane potential (DC m ) precedes PS externalization and this effect, specific to DOXO and not seen with etoposide (a reference topoisomerase II poison), is independent of a caspase-or Bcl2-controlled checkpoint (Huigsloot et al., 2001) . Our data are coherent with these previous Figure 7 Transmission electron microscopic images of H9C2 cells treated for 18 h with DOXO (c, Â 73000, d, Â 7300 and e, Â 48500) or without drug (controls in a, Â 7300 and b, Â 17000). Cells and mitochondria with representative morphological features are shown. Note the typical picture of mitochondrial swelling with mitochondrial outer membrane disruption associated with RE dilatation (e) which are missing in (a) and (b) Doxorubicin-induced proliferation of mitochondria J Kluza et al reports. We confirm the proapoptotic effects of DOXO in this cell line, and most importantly, we demonstrate that proliferation of mitochondria precedes nuclear apoptosis in DOXO-treated MTLn3 cells.
The mitochondrial proliferation was not detected in H9C2 cells (and in primary cardiomyocytes), but nevertheless these cardiac cells undergo apoptosis, as evidenced by the TUNEL, cell cycle and Western blot data. Induction of apoptosis in H9C2 cells exposed to DOXO has been recently correlated with the generation of ROS and mitochondrial dysfunctions (Green and Leeuwenburgh, 2002 ). An analogous observation has been made at the clinical level. The loss of myocardial function in patients receiving DOXO chemotherapy is linked to drug-induced mitochondrial dysfunction (Zhou et al., 2001 ).
The fluorescence data indicate an accumulation of the fluorescent probe JC1 in mitochondria of MTLn3 cells but not in H9C2 cells. The effect is not restricted to MTLn3 cells as it was also detected in three other tumor cell lines (HL-60, MCF7 and HeLa), but not in primary cardiomyocytes isolated from rat heart. At first sight, the fluorescence increase can be attributed to swelling of individual mitochondrion and/or to proliferation of mitochondria. The microscopy data support the later possibility. The number of mitochondria is markedly increased in MTLn3 cells treated with DOXO and these mitochondria showed no significant sign of swelling and remained essentially intact and functional. To the best of our knowledge, the proliferation of mitochondria in cancer cells exposed to DOXO has not been reported previously. Mitochondrial proliferation has been reported in several isolated cases, such as (i) in colon adenocarcinoma Colo-205 cells exposed to the tyrosine kinase inhibitor herbimycin A (Mancini et al., 1997), (ii) in different tumor cell lines treated with genistein (Pagliacci et al., 1993) (Reipert et al., 1995) and HL-60 cells (Eliseev et al., 2003) after treatment with etoposide and (vi) in osteosarcoma 143B cells treated with taxol, which stabilizes microtubules (Karbowski et al., 2000) . The reasons for this specific effect are not precisely known at present but different hypothesis can be advanced. The apparent proliferation may also result from a fragmentation process. A fragmentation of the mitochondrial network has been observed during the early stages of apoptotic cell death, a process which may depend on the participation of the dynamin-related GTPase Drp1 (Karbowski and Youle, 2003) . Although we had no sign of a fission-based mechanism from the electron microscopy data, this hypothesis must be considered. However, the hypothesis that we consider as a priority is to implicate ROS in the process. An oxidative stress, such as the (e.g. treatment of cells with hydrogen peroxide) suffices to stimulate mitochondrial proliferation in H9C2 and MTLn3 cells and the effect is more pronounced in the tumor cells compared to the cardiac cells, as it is the case with DOXO. This result is consistent with reported observations that hydrogen peroxide induces an increase of the mitochondrial mass in human cells (Lee et al., 2000 (Lee et al., , 2002 and there is no doubt that DOXO is a potent oxidative agent capable of generating a substantial amount of ROS in mitochondria Doroshow and Davies, 1986) . The cytometry experiments using the probe H 2 DCF-DA attest for the production of ROS in our cell models and the fact that the ROS production is higher in MTLn3 cells than in H9C2 cells may be linked to the mitochondrial proliferation observed specifically in the cancer cell line. Mitochondrial oxidative phosphorylation is the major endogenous source of ROS in cells and apoptosis has been linked to the activation of genes involved in the production of ROS (Polyak et al., 1997) . ROS production in DOXO-treated cells can result from the induction of specific genes associated with ROS production and also from a direct effect of the drug. The pro-oxidant behavior of DOXO is commonly attributed to one-electron reduction of the quinone moiety. The oxidative stress induced by DOXO, whatever its molecular origin, is certainly a key event implicated for triggering cell cycle arrest and induction of an increase of the mitochondrial mass. At present, it is not known whether the mitochondrial proliferation is a defense mechanism exploited by certain tumor cells to combat the oxidative stress produced by DOXO or a peculiar drug-induced suicide mechanism activated by the drug to amplify the apoptotic response. Using CHO cells exposed to aphidicolin (which inhibits DNA polymerase a and arrests cells in G1/S), it has reported that mitochondrial proliferation does not represent a survival pathway for CHO cells but rather corresponds to a deleterious effect to cell survival (Camilleri-Broet et al., 1998) .
When DOXO is administered, mitochondria are continuously exposed to a relatively high level of ROS and free radicals. Tight binding of DOXO to nucleic acids leads to the production of H 2 O 2 in the cell nuclei, which not only can serve to damage mtDNA but can also function as molecular relay to amplify the oxidative stress at the nuclear level. Indeed, H 2 O 2 would be involved in the communication between mitochondria and the nucleus (Poyton and McEwen, 1996) . Therefore, the mitochondrial proliferation might further cause oxidative damage to nucleic acids in nuclei. In other words, based on our results and the literature data, we suggest that the production of H 2 O 2 and other ROS by DOXO is responsible for the proliferation of mitochondria in MTLn3 cells, which in turn serves to amplify the damaging events occurring at the nuclear level. The increase in mitochondria in an MTLn3 cell exposed to DOXO could supply the surrounding nucleus with more proapoptotic factors and/or more oxidative damage to different intracellular constituent. A 'vicious cycle' is thus established where drug-induced mitochondrial dysfunctions amplify nuclear damages and vice versa. This hypothesis places mitochondrial proliferation at the top of a molecular cascade leading to cell death. The outcome of the events leading to the increase in the mitochondrial mass would be dependent on the nature and intensity of the oxidative stress and also, as usual, on the nature of the target cells and its susceptibility to cope with an insult of ROS. The proliferation of mitochondria could explain the higher toxicity of DOXO to cancer cells compared to cardiac cells. Cardiomyocytes are ill-equipped with oxyradical-detoxyfying enzymes (e.g. superoxide dismutase, catalase, glutathion peroxidase) and this explains, at least partially, why DOXO becomes toxic to heart but not to other tissues (Singal and Iliskovic, 1998; Minotti et al., 1999) .
The general idea is that the distinct alterations in mitochondria functions observed in tumor cells and cardiac cells reflect two different model of apoptosis induced by an anticancer drug. The idea that one anticancer drug can stimulate two distinct apoptosis pathways is clearly evidenced in the present study. The goal now would be to promote induction of apoptosis in cancer cells while reducing the extent of apoptosis in cardiac cells. This may be done by using agents that specifically stimulate mitochondrial proliferation. In this respect, the use of drugs targeting the nitric oxide signaling pathway may provide an opportunity to regulate mitochondrial number and functions (BossyWetzel and Lipton, 2003) .
Materials and methods
Drugs and chemicals
Mitoxantrone (Novantrone s , Wyeth-Lederle, Paris, France) and DOXO (Sigma Chemical Co., La Verpillie`re, France) were dissolved in water. RNase A, PI, carbonyl cyanide pchlorophenylhydrazone (mClCCP) were purchased from Sigma Chemical Co. JC-1, H 2 DCF-DA, MTG and DAPI) were from Molecular Probes (Eugene, OR, USA). Phiphilux G1D2 was from OncoImmunin Inc. (College Park, MD, USA).
Cells and culture conditions
The embryonic rat heart-derived cell line H9C2, HL-60 human leukemia cells, MCF-7 human breast adenocarcinoma and HeLa human cervix adenocarcinoma cells were obtained from the American Type Culture Collection. The rat mammary adenocarcinoma cell line MTLn3 was kindly provided by Dr RA Mooney (University of Rochester School of Medicine and Dentistry) (Levea et al., 2000) . H9C2 and MTLn3 cells were grown at 371C under 5% CO 2 /air in DMEM or aMEM, respectively, containing 100 U/ml penicillin, and 0.1 ng/ml streptomycin and supplemented with 10% heat-inactivated fetal calf serum (FCS). Cardiomyocytes from adult male Sprague-Dawley rats (Depre´, Saint Doulchard, France) were isolated by collagenase perfusion as recently described (Favory et al., 2004) . H9C2, MCF-7 and rat cardiomycytes were grown at 371C under 5% CO 2 /air in DMEM, containing 100 U/ml penicillin, and 0.1 ng/ml streptomycin and supplemented with 10% heat-inactivated FCS. MTLn3 and HL-60 were grown in same condition, but in RPMI or aMEM medium. Cells were treated with DOXO and MITO under strictly identical conditions. In the exponential phase of growth, the doubling time of both cell lines ranged from 20 to 30 h. Subconfluent cells were seeded in six-well dishes and incubated with the test drug in the specific medium containing 1% heat-inactivated FCS. Floating cells were recovered from culture medium by centrifugation at 300 g for 5 min, and adherent cells were harvested by trypsinization (trypsin 0.25%, 10 min, 371C). Both floating and adherent cells were used for the experiments.
Trypan blue dye exclusion assay and morphological assessment of apoptosis
The cell suspension was mixed with an isotonic solution of trypan blue (0.2%; w/v) and the drug toxicity was determined by counting stained cells using a hemocytometer chamber under a light microscope (Leica DLMB). For the morphological assessment of apoptosis by light microscopy, cells were stained with the standard Papanicolaou procedure.
Analysis of nuclear apoptosis
The frequency of hypoploid cells (sub-G1 cells) was assessed by studying the cell cycle after fixation overnight at 41C with 70% ice-cold ethanol/phosphate-buffered saline (PBS) followed by staining with a solution containing PI (50 mg/ml) and RNase A (0.5 mg/ml), and analysed with a Becton Dickinson FACScan cytofluorometer. Chromatin condensation was assessed by staining cells with DAPI (2.5 mg/ml) after fixation of cells in 70% cold ethanol for 4 h (at Â 201C), then nuclear morphology was visualized by fluorescence microscopy using a Zeiss microscope with a Â 63 or Â 100 oil objective. Images were captured using the software Quips Smart Capture (Vysis). In situ nuclear DNA fragmentation was measured according to the conventional TUNEL method based on 3 0 -OH end labeling of DNA breaks with deoxyuridine terminal deoxynucleotidyl transferase (TdT). The Apoptosis Detection System fluorescein (Promega) was used according to the supplier's recommendations. Briefly, 1 Â 10 6 cells were treated with DOXO or MITO for 24 h, and then 30 000 cells were collected and centrifuged (cytospin) at 500 r.p.m. for 5 min. Cells were fixed by immersion in a 3% ice-cold paraformaldehyde solution (3 g; 0.1 mM CaCl 2 , 0.1 mM MgCl 2 , 100 ml PBS, pH 7.4) for 25 min at 41C. Fixed cells were washed twice with PBS and made permeable in PBS containing Triton X-100 for 5 min in ice. Slides were rinsed twice in PBS. Excess PBS was drained off, and 100 ml of equilibration buffer was added for 5-10 min at room temperature for a pre-equilibration. DNA strand breaks (3 0 -OH ends of fragmented DNA) were labeled with fluorescein-12-dUTP by adding incubation buffer containing equilibration buffer (45 ml), nucleotide mix (5 ml) and terminal deoxynucleotidyl transferase (1 ml) (volumes used per slide). After incubation in the dark at 371C for 1 h, slides were dipped into 2 Â standard saline citrate to stop the reaction. After two successive washes, PI (1 mg/ml) was added to stain all cells. Apoptotic cells were detected by fluorescence microscopy. The nuclei of cells containing intact genomic DNA appeared in red (due to PI staining), whereas apoptotic cells were also green due to the incorporation of FITC-dUTP, thus reflecting the occurrence of DNA fragmentation.
Cytofluorometric analysis of peroxides production
The production of peroxides was determined using H 2 DCF-DA, a nonfluorescent substance which is oxidized by hydrogene peroxide and peroxinitrite to give DCF, a product emitting green fluorescence. Cells (5 Â 10 5 /ml) were exposed for 30 min at 371C to 5 mM H 2 DCF-DA before cytofluorometric analysis (excitation 488 nm; emission 575 nm). DCF fluorescence was detected and the mean fluorescence intensity (MFI) was measured.
Fluorometric analysis of caspase-3 activity
A detection of caspase 3-like activities in cytosolic fraction of cells was assayed using the Enz Check Caspase-3 Assay Kit from Molecular probes. After incubation with the test drug, cells (1 Â 10 6 /ml) were incubated for 1 2 h with 50 ml of the lysis buffer (Tris pH 7.5, 0.1 M NaCl, 1 mM EDTA, 0.01% Triton X-100). Lysed cells were centrifuged to pellet cellular debris. The supernatant (50 ml) was incubated with Z-DEVD-R110 substrate in the reaction buffer (10 mM PIPES, pH 7.4, 2 mM EDTA, 0.1% CHAPS) for 1 2 h at room temperature. The MFI was measured under excitation at 496 nm and emission at 520 nm.
Cytofluorometric analysis of mitochondrial changes
To evaluate the mitochondrial transmembrane potentials (Dc m ), a procedure described previously was followed (Kluza et al., 2000 (Kluza et al., , 2002 . Briefly, cells (5 Â 10 5 /ml) were incubated for 30 min at 371C with JC-1 (1 mM in PBS). Samples were stored in ice prior to the cytofluorometric analysis. JC-1 exists as a monomer at low values of Dc m (green fluorescence, emission 527 nm), while it forms aggregates at high Dc m (orange fluorescence, emission 590 nm). Control cells were incubated in the presence of 50 mM mClCCP (an uncoupling agent that abolishes Dc m ) for 30 min at 371C, washed twice and labeled with JC-1.
Changes in mitochondrial mass were analysed with the mitochondrion-specific dye MTG. This fluorochrome appears to preferentially accumulate in mitochondria regardless of the mitochondrial membrane potential. MTG (100 nM) was added at the cell suspension (5 Â 10 5 /ml) and incubated for 30 min at 371C. Monoparametric analysis was performed on the Fl1 channel and the MFI was measured. Mitochondria were counted by direct observations under the electron microscope. Comparison of number of mitochondria per cell was performed using variance analysis and Student t-test. Significance level was fixed at P ¼ 0.05.
Immunoblotting
Cells were harvested in RIPA buffer (PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) containing 10 mg/ml aprotinin, leupeptin and 5 mM PMSF and incubated for 1 h on ice. For caspase-3 or Bcl-2, lysates were centrifugated at 14 000 Â g and 50 mg of supernatant was loaded on 12% polyacrylamide gel, electrophoresed and transferred onto a nitrocellulose membrane (Amersham Life Science). Activated caspase-3 was detected using an anti-caspase-3 antibody (1:1000, Cell Signaling Technology Inc., ref 9661), which recognizes the 17 kDa subunit of caspase-3 resulting from cleavage adjacent to Asp 175. Bcl-2 was detected using a polyclonal rabbit antiBcl-2 antibody (1:1000, Santa Cruz, sc-783).
For detection of mitochondrial proteins release, cytosolic protein extracts were prepared as previously described (Marchetti et al., 1999) . In all, 50 mg of protein from each sample of the cytosolic fraction were loaded on a 12% polyacrylamide gel. After electrophoresis, the gels were blotted onto a nitrocellulose membrane (Amersham Life Sciences), which was then probed with a mouse Ab 7H8.2C12 (1/1000; Pharmingen) specifically recognizing the denatured form of cytochrome c or a mouse Ab raised against AIF (1 : 1000, sc-13116, Santa Cruz Biotechnology, Inc.).
Immunoblot with anti-G3PDH rabbit polyclonal IgG Ab (1 : 2000, Trevigen, Gaithersburg, MD, USA) was used for standardization of protein loading. Primary antibodies binding was detected with a horseradish peroxidase-conjugated goat anti-mouse or goat anti-rabit IgGs (Biorad) (both at dilution 1 : 1000) and visualized by enhanced chemiluminescence (ECL Plus) following the manufacturer's instructions (Amersham).
Transmission electron miscroscopy
H9C2 or MTLn3 cells were treated with DOXO for 18 h. Cells were harvested, and fixed with 2.5% glutaraldehyde in cacodylate buffer (pH 7.2, 0.1 M) for 60 min at room temperature. They were washed three times with cacodylate buffer. Postfixation was performed in 1% osmic acid for 60 min at room temperature. Cells were embedded in Araldite after dehydratation in ethanol. Sections were collected on parlodion-coated nickel grids counterstained successively in water and lead citrate before observation with a Zeiss 902 electron microscope.
Abbreviations DOXO, doxorubicin; FCS, ftal calf serum; MFI, mean of fluorescence intensity; MITO, mitoxantrone; PBS, phosphatebuffered saline; ROS, reactive oxygen species.
